BHC BAUSCH HEALTH COMPANIES INC Company Mergers 8-K Filing 2023 - Acquisition of XIIDRA and ophthalmology assets Bausch Health Companies Inc. filed an amendment to announce the completion of the acquisition of XIIDRA and other ophthalmology assets by its subsidiary Bausch + Lomb, and to provide financial statements and pro forma financial information related to the acquisition.Get access to all SEC 8-K filings of the BAUSCH HEALTH COMPANIES INC